Literature DB >> 11952092

The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Tomas C Bellamy1, John Garthwaite.   

Abstract

Soluble guanylyl cyclase (sGC) is the main receptor for nitric oxide (NO), and so mediates a wide range of effects (e.g. vasodilatation, platelet disaggregation and neural signalling) through the accumulation of cGMP and the engagement of various downstream targets, such as protein kinases and ion channels. Until recently, our understanding of sGC functioning has been derived exclusively from studies of the enzyme in tissue homogenates or in its purified form. Here, NO binds to the haem prosthetic group of sGC, triggering a conformational change and a large increase in catalytic activity. The potency (EC50) of NO appears to be about 100-200 nM. The rate of activation of sGC by NO is rapid (milliseconds) and, in the presence of excess substrate, cGMP is formed at a constant rate; on removal of NO, sGC deactivates slowly (seconds-minutes). Recent investigation of the way that sGC behaves in its natural environment, within cells, has revealed several key differences. For example, the enzyme exhibits a rapidly desensitizing profile of activity; the potency of NO is 45 nM for the minimally-desensitized enzyme but becomes higher with time, deactivation of sGC on removal of NO is 25-fold faster than the fastest estimate for purified sGC. Overall, within cells, sGC behaves in a way that is analogous to the way that classical neurotransmitter receptors operate. The properties of cellular sGC have important implications for the understanding of NO-cGMP signalling. For example, the dynamics of the enzyme means that fluctuations in the rate of NO formation, even on subsecond time scale, will result in closely synchronized sGC activity in neighbouring cells; desensitization of sGC provides an economical way of generating a cellular cGMP signal and, in concert with phosphodiesterases, provides the basis for cGMP signal diversity, allowing different targets (outputs) to be selected from a common input (NO). Thus, despite exhibiting only limited molecular heterogeneity, cellular sGC functions in a way that introduces speed, complexity, and versatility into NO-cGMP signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952092

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  77 in total

Review 1.  Studying the structure and regulation of soluble guanylyl cyclase.

Authors:  D Koesling
Journal:  Methods       Date:  1999-12       Impact factor: 3.608

2.  Calcium--a life and death signal.

Authors:  M J Berridge; M D Bootman; P Lipp
Journal:  Nature       Date:  1998-10-15       Impact factor: 49.962

3.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

Review 4.  Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs).

Authors:  D M Juilfs; S Soderling; F Burns; J A Beavo
Journal:  Rev Physiol Biochem Pharmacol       Date:  1999       Impact factor: 5.545

5.  Localization of the heme binding region in soluble guanylate cyclase.

Authors:  Y Zhao; M A Marletta
Journal:  Biochemistry       Date:  1997-12-16       Impact factor: 3.162

6.  Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.

Authors:  L R Potter
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

7.  Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation.

Authors:  R Ferrero; F Rodríguez-Pascual; M T Miras-Portugal; M Torres
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

8.  Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells.

Authors:  M Kelm; M Feelisch; R Spahr; H M Piper; E Noack; J Schrader
Journal:  Biochem Biophys Res Commun       Date:  1988-07-15       Impact factor: 3.575

9.  Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties.

Authors:  J Wood; J Garthwaite
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

10.  Functional properties of a naturally occurring isoform of soluble guanylyl cyclase.

Authors:  M Russwurm; S Behrends; C Harteneck; D Koesling
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

View more
  17 in total

1.  Nitric oxide activation of guanylyl cyclase in cells revisited.

Authors:  Brijesh Roy; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

Review 2.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

Review 3.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

Review 4.  Regulation and function of cyclic GMP-mediated pathways in glial cells.

Authors:  María Antonia Baltrons; Mariela Susana Borán; Paula Pifarré; Agustina García
Journal:  Neurochem Res       Date:  2008-04-01       Impact factor: 3.996

5.  Glucagon-like peptide-2 (GLP-2) modulates the cGMP signalling pathway by regulating the expression of the soluble guanylyl cyclase receptor subunits in cultured rat astrocytes.

Authors:  Esther Velázquez; Enrique Blázquez; Juan Miguel Ruiz-Albusac
Journal:  Mol Neurobiol       Date:  2012-07-18       Impact factor: 5.590

Review 6.  NO-cGMP signaling and regenerative medicine involving stem cells.

Authors:  K S Madhusoodanan; Ferid Murad
Journal:  Neurochem Res       Date:  2006-10-18       Impact factor: 3.996

7.  Localization of soluble guanylyl cyclase in the superficial dorsal horn.

Authors:  Jin-Dong Ding; Richard J Weinberg
Journal:  J Comp Neurol       Date:  2006-04-20       Impact factor: 3.215

8.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

Review 9.  Endogenous production of H2S in the gastrointestinal tract: still in search of a physiologic function.

Authors:  David R Linden; Michael D Levitt; Gianrico Farrugia; Joseph H Szurszewski
Journal:  Antioxid Redox Signal       Date:  2010-05-01       Impact factor: 8.401

10.  Plasma membrane cholesterol content affects nitric oxide diffusion dynamics and signaling.

Authors:  Shane Miersch; Michael Graham Espey; Ruchi Chaube; Arzu Akarca; Rodney Tweten; Sirinart Ananvoranich; Bulent Mutus
Journal:  J Biol Chem       Date:  2008-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.